• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药联合六字诀呼吸操在肺癌术后生理康复中的应用:一项前瞻性倾向评分匹配研究。

Chinese Herbal Medicine Combined With Liuzijue Exercise in Physiological Rehabilitation After Video-assisted Lung Lobectomy for Cancer: A Prospective Propensity Score Matching Study.

机构信息

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

出版信息

Integr Cancer Ther. 2024 Jan-Dec;23:15347354241261977. doi: 10.1177/15347354241261977.

DOI:10.1177/15347354241261977
PMID:38907709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11193924/
Abstract

OBJECTIVE

To observe the clinical efficacy of Chinese herbal medicine combined with Liuzijue exercise on the physiological symptoms and quality of life (QoL) in postoperative patients with early-stage lung cancer.

METHODS

One hundred and eighty-three lung cancer patients who underwent video-assisted thoracoscopic surgery (VATS) were categorize into either a traditional Chinese medicine treatment group (CM) or a control group (non-traditional Chinese medicine treatment, NC), among whom 73 underwent Chinese herbal medicine and Liuzijue therapy, while 110 underwent no comprehensive treatment with traditional Chinese medicine. The propensity score matching (PSM) method with a 1:2 ratio was used to balance the baseline characteristics and evaluate the efficacy of CM in improving postoperative symptoms and QoL.

RESULTS

Cough, dyspnea, chest pain, and fatigue were the most common clinical symptoms after VATS. Except for chest pain, they were all correlated with the scope of operation ( < .05). After PSM, 165 patients were identified in the matched cohort, and the covariates of gender, age, operative site, and scope of operation were balanced between the 2 groups ( > .05). In the domain of global health status, the improvement in QoL in CM was greater than that in NC (6.06 ± 15.83 vs -1.06 ± 14.68,  = .005). In terms of symptoms, improvements in cough (1.69 ± 3.15 vs 0.38 ± 2.63,  = .006), dyspnea during climbing stairs (-10.30 ± 16.82 vs -1.82 ± 17.97,  = .004), and pain (-0.76 ± 1.32 vs -0.08 ± 1.31,  = .002) in CM were better than in NC.

CONCLUSION

Comprehensive treatment with traditional Chinese medicine (TCM) can provide therapeutic benefits in physiological rehabilitation after VATS for cancer.

摘要

目的

观察中药联合六字诀锻炼对早期肺癌术后患者生理症状和生活质量(QoL)的临床疗效。

方法

将 183 例接受电视胸腔镜手术(VATS)的肺癌患者分为中药治疗组(CM)和对照组(非中药治疗,NC),其中 73 例采用中药和六字诀治疗,110 例未采用中药综合治疗。采用倾向性评分匹配(PSM)方法,1:2 比例平衡基线特征,评估 CM 改善术后症状和 QoL 的疗效。

结果

VATS 后咳嗽、呼吸困难、胸痛和乏力是最常见的临床症状,除胸痛外,均与手术范围有关( < .05)。PSM 后,匹配队列中确定了 165 例患者,2 组的性别、年龄、手术部位和手术范围的协变量均衡( > .05)。在整体健康状况领域,CM 的 QoL 改善大于 NC(6.06 ± 15.83 与-1.06 ± 14.68,  = .005)。在症状方面,CM 组的咳嗽(1.69 ± 3.15 与 0.38 ± 2.63,  = .006)、爬楼梯时呼吸困难(-10.30 ± 16.82 与-1.82 ± 17.97,  = .004)和疼痛(-0.76 ± 1.32 与-0.08 ± 1.31,  = .002)的改善均优于 NC。

结论

综合应用中药治疗可促进 VATS 后癌症患者生理康复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/3e94c3353f69/10.1177_15347354241261977-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/dbcac98990c6/10.1177_15347354241261977-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/51ba3816ab78/10.1177_15347354241261977-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/b0bc7f646195/10.1177_15347354241261977-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/3e94c3353f69/10.1177_15347354241261977-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/dbcac98990c6/10.1177_15347354241261977-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/51ba3816ab78/10.1177_15347354241261977-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/b0bc7f646195/10.1177_15347354241261977-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd40/11193924/3e94c3353f69/10.1177_15347354241261977-fig4.jpg

相似文献

1
Chinese Herbal Medicine Combined With Liuzijue Exercise in Physiological Rehabilitation After Video-assisted Lung Lobectomy for Cancer: A Prospective Propensity Score Matching Study.中药联合六字诀呼吸操在肺癌术后生理康复中的应用:一项前瞻性倾向评分匹配研究。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241261977. doi: 10.1177/15347354241261977.
2
Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study.中药对非小细胞肺癌(NSCLC)术后康复的疗效:一项随机对照研究
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251314529. doi: 10.1177/15347354251314529.
3
[Quality of life after lobectomy for early stage non-small cell lung cancer--video-assisted thoracoscopic surgery versus minimal incision thoracotomy].[早期非小细胞肺癌肺叶切除术后的生活质量——电视辅助胸腔镜手术与微创开胸手术对比]
Ai Zheng. 2007 Jun;26(6):624-8.
4
Postoperative pulmonary complications and rehabilitation requirements following lobectomy: a propensity score matched study of patients undergoing video-assisted thoracoscopic surgery versus thoracotomy†.肺叶切除术后的肺部并发症及康复需求:一项倾向性评分匹配研究,比较接受电视辅助胸腔镜手术与开胸手术的患者†
Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):931-937. doi: 10.1093/icvts/ivx002.
5
Comparison of Early Functional Recovery Following Triportal Robot-Assisted and Uniportal Video-Assisted Segmentectomy in Patients With Early-Stage Non-Small Cell Lung Cancer: A Propensity Score-Matched Analysis.三孔机器人辅助与单孔电视辅助肺段切除术治疗早期非小细胞肺癌患者的早期功能恢复比较:倾向评分匹配分析
Thorac Cancer. 2025 Mar;16(5):e70041. doi: 10.1111/1759-7714.70041.
6
[Comparison of the efficacy of robot assisted and thoracoscopic assisted thoracic surgery in non-small cell lung cancer].机器人辅助与胸腔镜辅助胸外科手术治疗非小细胞肺癌的疗效比较
Zhonghua Yi Xue Za Zhi. 2024 Sep 3;104(34):3221-3227. doi: 10.3760/cma.j.cn112137-20240226-00410.
7
Comparison of early postoperative patient-reported outcomes after multiportal robotic-assisted thoracoscopic surgery and uniportal video-assisted thoracoscopic surgery for non-small cell lung cancer.多通道机器人辅助胸腔镜手术与单通道电视胸腔镜手术治疗非小细胞肺癌的术后早期患者报告结局比较。
Eur J Surg Oncol. 2024 Sep;50(9):108481. doi: 10.1016/j.ejso.2024.108481. Epub 2024 Jun 12.
8
Long-term outcomes of open and video-assisted thoracoscopic lung lobectomy for the treatment of early stage non-small cell lung cancer are similar: a propensity-matched study.开放性与电视辅助胸腔镜肺叶切除术治疗早期非小细胞肺癌的长期疗效相似:一项倾向评分匹配研究
World J Surg. 2015 May;39(5):1084-91. doi: 10.1007/s00268-014-2918-z.
9
Propensity score-matching analysis of hybrid video-assisted thoracoscopic surgery and thoracoscopic lobectomy for clinical stage I lung cancer†.混合电视辅助胸腔镜手术与胸腔镜肺叶切除术治疗临床I期肺癌的倾向评分匹配分析†
Eur J Cardiothorac Surg. 2016 Apr;49(4):1063-7. doi: 10.1093/ejcts/ezv296. Epub 2015 Aug 30.
10
[Comparison Study of Post-operative Pain and Short-term Quality of Life between Uniportal and Three Portal Video-assisted Thoracic Surgery for Radical Lung Cancer Resection].单孔与三孔电视辅助胸腔镜手术根治性肺癌切除术后疼痛及短期生活质量的比较研究
Zhongguo Fei Ai Za Zhi. 2016 Mar;19(3):122-8. doi: 10.3779/j.issn.1009-3419.2016.03.02.

引用本文的文献

1
A score prediction model for predicting the heterogeneity symptom trajectories among lung cancer patients during perioperative period: a longitudinal observational study.一种用于预测肺癌患者围手术期异质性症状轨迹的评分预测模型:一项纵向观察性研究。
Ann Med. 2025 Dec;57(1):2479588. doi: 10.1080/07853890.2025.2479588. Epub 2025 Mar 20.

本文引用的文献

1
Efficacy and Influencing Factors of Sangju Cough Mixture in the Adjuvant Treatment of Adult Patients with Infection: A Retrospective Study.桑菊止咳合剂辅助治疗成人感染患者的疗效及影响因素:一项回顾性研究
Infect Drug Resist. 2024 Jan 26;17:275-282. doi: 10.2147/IDR.S438202. eCollection 2024.
2
Shengxian decoction protects against chronic heart failure in a rat model via energy regulation mechanisms.圣仙汤通过能量调节机制保护大鼠慢性心力衰竭。
BMC Complement Med Ther. 2023 Jun 17;23(1):200. doi: 10.1186/s12906-023-04035-3.
3
Liuzijue training improves hypertension and modulates gut microbiota profile.
六字诀训练可改善高血压并调节肠道微生物群谱。
Front Cardiovasc Med. 2023 Jan 25;10:1075084. doi: 10.3389/fcvm.2023.1075084. eCollection 2023.
4
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
5
Post-infectious cough of different syndromes treated by traditional Chinese medicines: A review.中药治疗不同证型感染后咳嗽的研究进展
Chin Herb Med. 2022 Sep 28;14(4):494-510. doi: 10.1016/j.chmed.2022.09.002. eCollection 2022 Oct.
6
Effect of Liuzijue on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: study protocol for a multicenter, non-randomized, prospective study.六字诀对慢性阻塞性肺疾病患者肺康复的影响:一项多中心、非随机、前瞻性研究方案。
BMC Complement Med Ther. 2022 Nov 17;22(1):296. doi: 10.1186/s12906-022-03789-6.
7
A review on the advances in the extraction methods and structure elucidation of Poria cocos polysaccharide and its pharmacological activities and drug carrier applications.关于茯苓多糖的提取方法、结构解析及其药理活性和药物载体应用的研究进展综述。
Int J Biol Macromol. 2022 Sep 30;217:536-551. doi: 10.1016/j.ijbiomac.2022.07.070. Epub 2022 Jul 16.
8
A nucleotide signature for the identification of Pinelliae Rhizoma (Banxia) and its products.一种用于鉴定半夏及其制品的核苷酸特征。
Mol Biol Rep. 2022 Aug;49(8):7753-7763. doi: 10.1007/s11033-022-07600-0. Epub 2022 Jun 7.
9
Chemical and Biological Evidence of the Efficacy of Shengxian Decoction for Treating Human Lung Adenocarcinoma.升仙汤治疗人肺腺癌疗效的化学与生物学证据
Front Oncol. 2022 Mar 18;12:849579. doi: 10.3389/fonc.2022.849579. eCollection 2022.
10
PPAR Alleviates Sepsis-Induced Liver Injury by Inhibiting Hepatocyte Pyroptosis via Inhibition of the ROS/TXNIP/NLRP3 Signaling Pathway.过氧化物酶体增殖物激活受体 α 通过抑制 ROS/TXNIP/NLRP3 信号通路抑制肝细胞核因子 4α 抑制肝损伤
Oxid Med Cell Longev. 2022 Jan 30;2022:1269747. doi: 10.1155/2022/1269747. eCollection 2022.